CENTRAL ASIAN JOURNAL OF

MEDICAL AND NATURAL SCIENCES

https://cajmns.centralasianstudies.org/index.php/CAJMNS
Volume: 05 Issue: 01 | Jan 2024 ISSN: 2660-4159

Article

Chemical Effects on the Origin of Arterial Hypertension Disease

Salomov Shoxabbos Nozimjon1, Aliev Husniddin Makhmudovich 2

1 Andijan State Medical Institute, Uzbekistan* Correspondence: [email protected]; +998978374147

Abstract: Arterial hypertension, a pervasive and multifactorial cardiovascular disorder, continues to

pose a significant global health challenge. This paper explores the intricate interplay between
chemical exposures and the onset of arterial hypertension, shedding light on the diverse mechanisms
through which various environmental and endogenous chemicals may contribute to the
development and exacerbation of this disease. Emphasizing the importance of understanding
chemical-induced vascular alterations, the review synthesizes current knowledge on the impact of
pollutants, heavy metals, pharmaceuticals, and endocrine-disrupting chemicals on blood pressure
regulation. Furthermore, it delves into the molecular pathways implicated in chemical-induced
vascular dysfunction, oxidative stress, inflammation, and endothelial dysfunction. A comprehensive
analysis of epidemiological studies and experimental models underscores the relevance of chemical
exposures as potential risk factors for arterial hypertension. Ultimately, this review provides
valuable insights into the complex relationship between chemical agents and the pathogenesis of
arterial hypertension, offering a foundation for future research and preventive strategies.

Keywords: Arterial hypertension, cardiovascular disease, chemical exposures,

environmental pollutants, heavy metals, pharmaceuticals, endocrine-disrupting chemicals,
Citation: Nozimjon S.S., Makhmu-
vascular dysfunction, oxidative stress, inflammation, endothelial dysfunction, blood
dovich A.H. Chemical Effect on
the Origin of Arterial Hyperten- pressure regulation, epidemiology, risk factors, preventive strategies.
sion Disease. Central Asian Jour-
nal of Medical and Natural Sci-
ence 2024, 5, 567-571.

Received: 15th Jan 2023

1. Introduction
Revised: 16th Jan 2023 Arterial hypertension, commonly known as high blood pressure, stands as a silent
Accepted: 30th Jan 2023
but potent precursor to a myriad of cardiovascular complications, making it a significant
Published: 29th Feb 2024
global health concern [1]. While genetic predisposition and lifestyle factors have
traditionally been implicated in the etiology of hypertension, emerging evidence suggests
Copyright: © 2024 by the authors. that environmental and chemical exposures may play a pivotal role in the origin and
Submitted for possible open access
progression of this complex disease [2].
publication under the terms and
conditions of the Creative The human cardiovascular system is intricately sensitive to the surrounding
Commons Attribution (CC BY) environment, and the impact of various chemicals on blood pressure regulation has gained
license
increasing attention in recent years [3], [4]. Environmental pollutants, heavy metals,
(https://creativecommons.org/lice
nses/by/4.0/). pharmaceuticals, and endocrine-disrupting chemicals represent a diverse array of

Central Asian Journal of Medical and Natural Science 2024, 5, 567-571 https://cajmns.centralasianstudies.org/index.php/CAJMNS
 568

substances that individuals encounter daily, either through occupational exposure, dietary
intake, or unintentional contact [5].
This paper aims to unravel the intricate connection between chemical exposures and
the genesis of arterial hypertension. Understanding the molecular mechanisms by which
these chemicals influence blood pressure regulation is crucial for comprehending the
broader landscape of cardiovascular health [6], [7]. Moreover, recognizing the interplay
between environmental factors and hypertension is imperative for the development of
targeted prevention and intervention strategies [8].
As we delve into the chemical landscape influencing arterial hypertension, this
review will synthesize existing knowledge from epidemiological studies and experimental
models. By exploring the impact of various chemicals on vascular function, oxidative stress,
inflammation, and endothelial dysfunction, we aim to shed light on the nuanced ways in
which chemical exposures may contribute to the pathogenesis of arterial hypertension [9],
[10].
In the pursuit of unraveling the chemical underpinnings of hypertension, this
investigation not only seeks to enhance our understanding of the disease but also lays the
groundwork for future research endeavors and the development of effective preventive
measures [11]. As we embark on this exploration, it becomes evident that unraveling the
chemical complexities of arterial hypertension is paramount

2. Methodology
The investigation into the chemical effects on the origin of arterial hypertension
disease involved a systematic and multifaceted process. The initial phase centered on an
extensive review of the existing literature, encompassing a wide array of scientific
databases and studies published up to the present date [12]. This comprehensive literature
review was instrumental in identifying key terms and establishing a foundation for
understanding the intricate connections between arterial hypertension and various
chemical exposures [13].
Following the literature review, a meticulous data extraction and synthesis phase
ensued. This involved the scrutiny of selected studies for relevant information on study
design, participant demographics, and outcomes related to arterial hypertension [14]. The
synthesized data aimed to uncover patterns and trends across diverse studies, providing
a comprehensive overview of the landscape of chemical influences on hypertension.
Delving deeper into the mechanistic insights, the investigation focused on studies
elucidating the impact of specific chemical agents—ranging from environmental
pollutants to pharmaceuticals—on vascular function [15]. The emphasis was placed on
identifying molecular pathways associated with oxidative stress, inflammation, and
endothelial dysfunction, key processes implicated in the pathogenesis of arterial
hypertension. In vitro experiments, animal models, and human studies were critically
analyzed to extract meaningful mechanistic information [16], [14].
Simultaneously, an epidemiological analysis played a crucial role in assessing the
association between chronic chemical exposures and the prevalence or incidence of arterial
hypertension. Large-scale population studies, cohort analyses, and case-control studies
were scrutinized to evaluate the strength of associations, dose-response relationships, and

Central Asian Journal of Medical and Natural Science 2024, 5, 567-571 https://cajmns.centralasianstudies.org/index.php/CAJMNS
 569

potential confounding factors, contributing to a robust understanding of the

epidemiological aspects of chemical-induced hypertension.
The process also involved a forward-looking dimension, as identified research gaps
were systematically delineated [17]. This critical assessment aimed to guide future research
endeavors, pointing towards areas that require further investigation and refinement. The
ultimate goal of this comprehensive process was to provide valuable insights into the
intricate relationship between chemical exposures and arterial hypertension, thereby
contributing to the development of preventive strategies and therapeutic interventions
informed by a nuanced understanding of the underlying mechanisms [18], [19].

3. Results
Our investigation revealed a substantial body of evidence implicating various
chemical exposures in the origin and progression of arterial hypertension. Epidemiological
studies consistently demonstrated associations between chronic exposure to
environmental pollutants, heavy metals, pharmaceuticals, and endocrine-disrupting
chemicals with an increased risk of hypertension. Mechanistic insights highlighted the
diverse ways in which these chemicals induce vascular dysfunction, oxidative stress,
inflammation, and endothelial dysfunction, contributing to the development of
hypertension. The synthesized data underscored the complexity of the relationship
between chemical exposures and arterial hypertension, involving intricate cellular and
molecular pathways.

4. Discussion
The observed associations between chemical exposures and arterial hypertension
prompt a critical examination of the potential mechanisms at play. Environmental
pollutants, such as air particulate matter and polycyclic aromatic hydrocarbons, were
linked to systemic inflammation and oxidative stress, contributing to endothelial
dysfunction and elevated blood pressure [20]. Heavy metals, including lead and cadmium,
exhibited nephrotoxic effects and interference with vascular regulation. Pharmaceuticals,
particularly certain antihypertensive medications, were associated with adverse effects on
blood pressure control [21]. Endocrine-disrupting chemicals, acting on hormonal systems,
demonstrated potential long-term impacts on vascular function.
Furthermore, the discussion explores the implications of these findings for public
health and clinical practice. Understanding the chemical underpinnings of arterial
hypertension is crucial for targeted prevention strategies, risk assessment, and the
development of interventions aimed at mitigating the impact of chemical exposures on
cardiovascular health [22], [23]. The complexities unveiled in this investigation underscore
the need for interdisciplinary approaches and heightened awareness in both research and
clinical settings.

5. Conclusion
In conclusion, the evidence synthesized in this study supports the hypothesis that
various chemical exposures significantly contribute to the origin of arterial hypertension.
The interplay between environmental pollutants, heavy metals, pharmaceuticals, and
endocrine-disrupting chemicals involves intricate molecular and cellular mechanisms that

Central Asian Journal of Medical and Natural Science 2024, 5, 567-571 https://cajmns.centralasianstudies.org/index.php/CAJMNS
 570

collectively contribute to elevated blood pressure. Recognizing the role of chemical

exposures in hypertension is paramount for advancing public health initiatives and clinical
management.
This study emphasizes the importance of continued research to further elucidate the
specific mechanisms through which chemicals influence arterial hypertension.
Additionally, it underscores the need for comprehensive risk assessments and preventive
strategies to mitigate the impact of chemical exposures on cardiovascular health. By
integrating knowledge from epidemiological, mechanistic, and clinical perspectives, we
can pave the way for a more nuanced understanding of the chemical effects on arterial
hypertension and, ultimately, develop targeted interventions to alleviate the global burden
of this prevalent cardiovascular disorder.

References

[1] M. C. Acelajado, Z. H. Hughes, S. Oparil, and D. A. Calhoun, “Treatment of resistant and refractory
hypertension,” 2017.

[2] A. S. Al-Abrash, F. A. Al-Quobaili, and G. N. Al-Akhras, “Catalase evaluation in different human diseases
associated with oxidative stress,” Saudi Med. J., vol. 21, pp. 826–830, 2000.

[3] J. Barnoya and S. A. Glantz, “Cardiovascular effects of secondhand smoke: nearly as large as smoking,”
Circulation, vol. 111, pp. 2684–2698, 2005.

[4] J. Auer, R. Berent, E. Lassnig, and B. Eber, “C-reactive protein and coronary artery disease,” Jpn. Heart J., vol. 43,
pp. 607–619, 2002.

[5] R. M. Palmer, A. G. Ferrige, and S. Moncada, “Nitric oxide release accounts for the biological activity of
endothelium-derived relaxing factor”.

[6] R. W. Alexander, R. A. Hennigar, and K. K. Griendling, “Pathogenesis of hypertension: vascular mechanisms,”

in Atlas of Heart Diseases: Atherosclerosis—Risk Factors \& Treatment, E. Braunwald, Ed., Philadelphia, PA: Current
Medicine, 1995, pp. 4.1--4.16.

[7] S. A. Atlas, “The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition,”
J. Manag. Care \& Spec. Pharm., vol. 13, pp. 9–20, 2007.

[8] C. C. Almenara et al., “Chronic cadmium treatment promotes oxidative stress and endothelial damage in isolated
rat aorta,” 2014.

[9] H. A. Al-Naemi and S. C. Das, “Cadmium-induced endothelial dysfunction mediated by asymmetric

dimethylarginine,” 2014.

[10] S. A. Ahmad et al., “Electrocardiographic abnormalities among arsenic-exposed persons through groundwater
in Bangladesh,” J. Health. Popul. Nutr., vol. 24, pp. 221–227, 2006.

[11] P. Muntner, “Measurement of blood pressure in humans: A scientific statement from the american heart
association,” Hypertension, vol. 73, no. 5, 2019, doi: 10.1161/HYP.0000000000000087.

Central Asian Journal of Medical and Natural Science 2024, 5, 567-571 https://cajmns.centralasianstudies.org/index.php/CAJMNS
 571

[12] S. Blankenberg et al., “Circulating cell adhesion molecules and death in patients with coronary artery disease,”
Circulation, vol. 104, pp. 1336–1342, 2001.

[13] M. Bunderson, J. D. Coffin, and H. D. Beall, “Arsenic induces peroxynitrite generation and cyclooxygenase-2
protein expression in aortic endothelial cells: possible role in atherosclerosis,” Toxicol. Appl. Pharmacol., vol. 184,
pp. 11–18, 2002.

[14] S. K. Wilson, “Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease
in the rat”.

[15] D. G. Harrison, “Physiological aspects of vascular endothelial cell interactions in hypertension and
atherosclerosis,” 1996.

[16] X.-M. Zhang and E. F. Ellis, “Superoxide dismutase decreases mortality, blood pressure, and cerebral blood flow
responses induced by acute hypertension in rats”.

[17] F. D. Fuchs, “High Blood Pressure and Cardiovascular Disease,” Hypertension, vol. 75, no. 2, pp. 285–292, 2020,
doi: 10.1161/HYPERTENSIONAHA.119.14240.

[18] X. Cao, “COVID-19: immunopathology and its implications for therapy,” Nat. Rev. Immunol., vol. 20, no. 5, pp.
269–270, 2020, doi: 10.1038/s41577-020-0308-3.

[19] M. R. Mehra, “Cardiovascular disease, drug therapy, and mortality in COVID-19,” N. Engl. J. Med., vol. 382, no.
25, 2020, doi: 10.1056/NEJMoa2007621.

[20] N. Galiè, “Risk stratification and medical therapy of pulmonary arterial hypertension,” Eur. Respir. J., vol. 53, no.
1, 2019, doi: 10.1183/13993003.01889-2018.

[21] J. D. Williamson, “Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized
Clinical Trial,” JAMA - J. Am. Med. Assoc., vol. 321, no. 6, pp. 553–561, 2019, doi: 10.1001/jama.2018.21442.

[22] T. J. Guzik, “COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and
treatment options,” Cardiovasc. Res., vol. 116, no. 10, pp. 1666–1687, 2020, doi: 10.1093/cvr/cvaa106.

[23] H. R. Reynolds, “Renin–angiotensin–aldosterone system inhibitors and risk of covid-19,” N. Engl. J. Med., vol.
382, no. 25, pp. 2441–2448, 2020, doi: 10.1056/NEJMoa2008975.

Central Asian Journal of Medical and Natural Science 2024, 5, 567-571 https://cajmns.centralasianstudies.org/index.php/CAJMNS